Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial. Journal of the American Society of Nephrology : JASN Lafayette, R., Tumlin, J., Fenoglio, R., Kaufeld, J., Pérez Valdivia, M. A., Wu, M. S., Susan Huang, S. H., Alamartine, E., Kim, S. G., Yee, M., Kateifides, A., Rice, K., Garlo, K., Barratt, J. 2024View details for DOI 10.1681/ASN.0000000534
View details for PubMedID 39455063